Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]:
SEC Accession No. 0001193125-15-418173
Filing Date
2015-12-31
Accepted
2015-12-30 21:02:09
Documents
2
Effectiveness Date
2015-12-31

Document Format Files

Seq Description Document Type Size
1 POS EX d44766dposex.htm POS EX 27765
2 EX-23.3 d44766dex233.htm EX-23.3 1708
  Complete submission text file 0001193125-15-418173.txt   30796
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS EX | Act: 33 | File No.: 333-208330 | Film No.: 151314773
SIC: 2834 Pharmaceutical Preparations